L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate(CAS: 357166-29-1)

L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate (CAS: 357166-29-1) is subject to various regulatory guidelines including GHS for hazardous classification, REACH for chemical registration, and FDA/EPA for safety and environmental standards. Detailed regulations may vary based on specific applications and jurisdictions.

In synthesis, alternatives to L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate (CAS: 357166-29-1) may include similar compounds like 2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl derivatives or other pyrimidine-based analogs. Isomers and alternative reagents can also be explored for specific chemical reactions.

The market for L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate (CAS: 357166-29-1) is driven by its applications in pharmaceuticals and research. Recent trends include increased interest in its potential therapeutic effects, particularly in oncology. Research is also focusing on its use in developing new drug delivery systems and addressing market demand for innovative chemical entities.

Waste containing L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate (CAS: 357166-29-1) should be managed by collecting it in appropriate containers and following local hazardous waste disposal regulations. Professional waste disposal services are recommended for safe incineration or other environmentally friendly disposal methods. Proper handling should also include precautionary measures to prevent environmental contamination and ensure safety of personnel.